Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study

@article{Bruckert2005MildTM,
  title={Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study},
  author={Eric Bruckert and Gilles Hayem and Sylvie Dejager and Caroline Yau and Bernard B{\'e}gaud},
  journal={Cardiovascular Drugs and Therapy},
  year={2005},
  volume={19},
  pages={403-414}
}
SummaryObjectives: To characterize the risk factors, rate of occurrence, onset, nature and impact of mild to moderate muscular symptoms with high-dosage HMG-CoA reductase inhibitor (statin) therapy in general practice.Methods: The Prédiction du Risque Musculaire en Observationnel (Prediction of Muscular Risk in Observational conditions, PRIMO) survey was an observational study of muscular symptoms in an unselected population of 7924 hyperlipidemic patients receiving high-dosage statin therapy… 
Statin-Associated Muscle Symptoms: SAM
TLDR
The epidemiology, the mechanism of action, and the management options for SAM include statin switching (to low dose or more hydrophilic), hold or discontinuation and/or need for additional therapy.
CHALLENGING CLINICAL ISSUE OF MUSCLE SYMPTOMS IN STATIN TREATED PATIENTS: A COMPARISON WITH AHA GUIDELINES
TLDR
There is strong evidence that statin lead to frequent muscle related adverse effects and may be challenging in some patientseven at lower doses than the recommendation of American Heart Association.
An insight into statin use and its association with muscular side effects in clinical practice
TLDR
In the studied set of patients muscular symptoms were a rather frequent effect of statin therapy, and could lead to more severe outcomes, their timely detection and management is important.
Statin-induced myopathy in a usual care setting—a prospective observational study of gender differences
TLDR
Women reported a higher frequency of myopathy and other ADRs as well as a larger impact on daily life activities as compared to men, which raises the question about common underlying mechanisms of statin-induced myopathy.
Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study
TLDR
Myalgia was the most common muscle adverse effect associated with statin therapy, and excessive alcohol consumption and pravastatin therapy were independently associated with myositis or rhabdomyolysis.
Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy
TLDR
A high number of risk factors may increase the probability of myotoxicity induced by statin therapy, and some of these, related to pharmacokinetic properties of statins and to concomitant therapies or patient characteristics, may affect statin bioavailability and increase vulnerability to high-dose statins.
Factors associated with statin-related adverse muscular events in adult dyslipidemic outpatients
TLDR
The results are suggestive that the type of statin prescribed and the concomitant use of ABCB1 inhibitors increase the susceptibility to adverse muscular events during statin therapy in dyslipidemic outpatients.
Treatment Options for Statin-Associated Muscle Symptoms.
TLDR
SAMS are important adverse effects of statin treatment because they lessen drug adherence and patients with SAMS should undergo a thorough diagnostic evaluation followed by appropriate counseling.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 43 REFERENCES
A Comprehensive Description of Muscle Symptoms Associated with Lipid-Lowering Drugs
TLDR
The role and importance of a genetic background predisposing to low-grade myopathy deserves further investigation, and the impact of these mild symptoms on daily activities might not be negligible in a subset of patients.
Can Statins Cause Chronic Low-Grade Myopathy?
  • S. Grundy
  • Medicine
    Annals of Internal Medicine
  • 2002
TLDR
Four patients who had muscle symptoms during statin therapy that resolved during placebo use were suggested to have statin-associated myopathy with normal serum creatine kinase levels, a novel approach that used quantitative measures of muscle strength and muscle biopsy to address the question of myopathy in patients in whom muscle symptoms are closely correlated with statin use.
Risk for myopathy with statin therapy in high-risk patients.
TLDR
Clinicians should be alert to the potential for drug-drug interactions to minimize the risk of myopathy during long-term statin therapy in patients at high risk for coronary heart disease.
Muscular Side Effects of Statins
TLDR
The data indicate that severe muscular side effects are rare and much more research should be directed onto the pathophysiological (genetic?) background to finally evaluate possible therapeutic consequences rather than simply to withdraw or change the respective statin.
Frequency of creatine kinase elevation during treatment with fluvastatin.
Rhabdomyolysis and HMG-CoA Reductase Inhibitors
TLDR
Rhabdomyolysis is a rare but clinically important adverse event of statin monotherapy or combination therapy and thorough understanding of this condition may help prevent or minimize adverse health outcomes in patients receiving statin therapy.
Adherence with statin therapy in elderly patients with and without acute coronary syndromes.
...
1
2
3
4
5
...